Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Acorda Therapeutics, Inc.

http://www.acorda.com

Latest From Acorda Therapeutics, Inc.

Abbott Surprises Industry With CE Mark For Freestyle Libre 3

The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.

Approvals Diabetic Care

Stockwatch: Esperion – Bonfire Of The Surrogates

For a biotech launching its first product the pandemic has compounded the usual pressures of a competitive indication against deeper-pocketed competition.

Stockwatch Companies

Sun Settles With Bausch Over Rifaximin

Sun Pharma and Bausch have decided to settle litigation over rifaximin, granting the generics company a non-exclusive license effective 1 January 2028.

Deals Legal Issues

Keeping Track: New Nucala Indication; BMS’ Ide-Cel Clears Filing Hurdle; First Applications From Telix And ADC Therapeutics

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Approvals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Drug Delivery
      • Pulmonary
  • Other Names / Subsidiaries
    • Neuronex, Inc.
    • Civitas Therapeutics
    • Biotie Therapies Corp.
    • Elbion GmbH
    • Synosia Therapeutics, Inc.
UsernamePublicRestriction

Register